Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Alternative 510(k) Proposal Falls Flat With Industry

Executive Summary

The US regulatory agency has touted its newly proposed voluntary "expanded abbreviated" 510(k) program as a modern approach to regulation that will simplify the path for many. But industry groups are mostly scratching their heads.

Advertisement

Related Content

Standards, Not Predicates Emphasized In Finalized Alternative 510(k) Pathway
An FDA Age-Based Predicate Policy Would Be Arbitrary, Reg Experts Complain
Nudging Firms To Ditch Older Predicates: A Step In US FDA's Planned 510(k) Reforms
Proposed 510(k) Changes Elicit Some Industry Skepticism
Proposed FDA Guidance Would Provide Alternate Route For 510(k) Applications
A No-Predicate 510(k) Future? Pending US FDA Policy Might Forge A Path

Topics

Advertisement
UsernamePublicRestriction

Register

MT123007

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel